Novus Therapeutics Inc (NVUS) Stock Analyst Ratings
NASDAQ:NVUS -
14.6
-0.8 (-5.19%)
15.75
+1.15 (+7.88%)
ChartMill assigns a Buy % Consensus number of 100% to NVUS. The Buy consensus is the weighted average rating of the current analysts ratings.
NVUS was analyzed by 2 analysts. The buy percentage consensus is at 100. So analysts seem to be very confident about NVUS.
In the last month the buy percentage rose by 20 points. So the trust of analysts is improving.
Only 2 analysts analyzed NVUS. So this is just the average opinion of a couple of analysts.